tradingkey.logo
tradingkey.logo
Suchen

LENSAR Inc

LNSR
Zur Watchlist hinzufügen
5.710USD
-0.010-0.17%
Handelsschluss 06/30, 16:00ETKurse um 15 Minuten verzögert
70.13MMarktkapitalisierung
2.34KGV TTM

mehr Informationen über LENSAR Inc Unternehmen

LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The Company has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.

LENSAR Inc Informationen

BörsenkürzelLNSR
Name des UnternehmensLENSAR Inc
IPO-datumSep 21, 2020
CEOCurtis (Nicholas T)
Anzahl der mitarbeiter140
WertpapierartOrdinary Share
GeschäftsjahresendeSep 21
Addresse2800 Discovery Drive
StadtORLANDO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl32826
Telefon18885367271
Websitehttps://www.lensar.com/
BörsenkürzelLNSR
IPO-datumSep 21, 2020
CEOCurtis (Nicholas T)

Führungskräfte von LENSAR Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
855.10K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
550.64K
--
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
246.41K
--
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
92.95K
--
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
88.21K
--
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Thomas R. Staab, II
Mr. Thomas R. Staab, II
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Ms. Elizabeth G. O'Farrell
Ms. Elizabeth G. O'Farrell
Independent Director
Independent Director
--
--
Mr. Thomas B. Ellis
Mr. Thomas B. Ellis
Independent Director
Independent Director
--
--
Mr. Todd B. Hammer
Mr. Todd B. Hammer
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
855.10K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
550.64K
--
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
246.41K
--
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
92.95K
--
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
88.21K
--
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von LENSAR Inc?

Die fünf größten Anteilseigner von LENSAR Inc sind: Mr. Nicholas T. (Nick) Curtis

Wie viele Institutionen halten Anteile an LENSAR Inc (LNSR)?

Mit Stand vom 2026Q1 halten 172 Institutionen Anteile an LENSAR Inc, mit einem Gesamtmarktwert von etwa 6.68M, was 55.41% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -342758.00 gestiegen.